New Cardiovascular Horizons (NCVH)
Avatar

Sirolimus Eluting Stents BTK: Outcomes and Safety

By New Cardiovascular Horizons (NCVH) FEATURING Sohail Khan
By New Cardiovascular Horizons (NCVH) FEATURING Sohail Khan
0 views
July 24, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

10:14
Boston Scientific

What not to leave behind? A surgical view of reintervention

Feat. Y. Gouëffic

Recommended

AUTOPLAY
10:19
Boston Scientific

What are we getting wrong with vessel preparation?

Feat. S. Steiner
01:46
Boston Scientific

The Challenges of the SFA

01:02
Boston Scientific

Dr. Lookstein IMPERIAL 2-Year Data

Feat. R. Lookstein
02:37
Boston Scientific

Drug-Eluting Stents: The Challenge

Feat. L. Garcia, M. Jaff, R. Lookstein
02:58
Boston Scientific

Drug-Eluting Stents: The Data

Feat. J. Diaz-Cartelle, R. Lookstein, L. Garcia
01:40
Boston Scientific

IMPERIAL Trial: First of its Kind Design

Feat. W. Gray, R. Lookstein, M. Jaff
02:12
Boston Scientific

IMPERIAL Trial: Influencing Treatment Algorithms

Feat. S. Henao, M. Jaff, W. Gray, R. Lookstein, G. Ansel
03:20
Boston Scientific

Drug-Eluting Stents: The Solution

Feat. J. Granada, M. Montero-Baker, A. Holden, G. Ansel
03:13
Boston Scientific

Drug-Eluting Stents: The Breakthrough

Feat. A. Holden, W. Gray, R. Lookstein, T. Zeller
02:28
Boston Scientific

Impact of the IMPERIAL Trial

Feat. M. Jaff, W. Gray, R. Lookstein, S. Henao, G. Ansel
52
Boston Scientific

Boston Scientific Drug-Eluting Technologies

Feat. R. Sachar
02:37
Boston Scientific

Drug-Eluting Stents: The Heritage

Feat. G. Ansel, M. Jaff, R. Lookstein, J. Diaz-Cartelle
03:43
Boston Scientific

The Design of a Drug-Eluting Stent System

14:09
ARCH Advanced Revascularization Symposium

What Is the Future of Drug-Eluting Technologies?

Feat. E. Dippel
23:45
NY Endovascular Summit

Subacute Occlusion Left SFA - Leipzig, Germany - LINC 2019

Feat. A. Schmidt
10:25
NY Endovascular Summit

Drug-Eluting Technology for Below-the-Knee Intervention

Feat. M. Bunte
17:27
ARCH Advanced Revascularization Symposium

Paclitaxel or Limus: What Is the Future in Drug Eluting Therapies?

Feat. C. Walker
20:01
ARCH Advanced Revascularization Symposium

What Stent to Use 2019

Feat. J. Singh
09:29
Boston Scientific

Clinical Update in Drug Eluting Technologies for PAD

Feat. P. Monteleone
15:07
ARCH Advanced Revascularization Symposium

Below the Knee Therapies: State of the Art

Feat. V. Kapur